Literature DB >> 1550874

Relationship of TNF to interleukins.

R Neta1, T J Sayers, J J Oppenheim.   

Abstract

It is evident from this review that TNF exhibits complex interactions with other cytokines at the level of production and in its effects. Studies designed to determine the role of TNF in the animal models or cell culture system using pure recombinant molecules have revealed that TNF never operates by itself, but instead operates within a network of cytokines. First, the multitude of exogenous as well as endogenous signals, which induce TNF production, concomitantly also stimulate the production of a battery of other inflammatory cytokines: IL-1, IL-6, IL-8, multiple CSFs, IFN, and TGF-beta. Moreover, TNF itself stimulates the production of most of these cytokines. Thus even when pure recombinant TNF is used, it readily generates the production of other interactive cytokines. This apparent redundancy in the production of cytokines with overlapping effects presumably has protective advantage for the host. Furthermore, interaction of these cytokines is more economical and amplifies the responses to subtoxic doses of potentially harmful cytokines. Cytokine interaction may lead to either synergistic (as for many TNF-IL-1 interactions) or antagonistic effects (TNF and TGF-beta, for example). These may depend on (1) the modulation of receptor expression of one cytokine by another (IFN-gamma-enhancing receptor expression for TNF, and TGF-beta down-regulation of IL-1 receptors), (2) stabilization of the cytokine message by one another (induction of IL-6 by TNF or IL-1), (3) interactions at the level of signal transduction, (4) gene expression, or (5) at the posttranslational level. Thus the receptor repertoire, which is a function of the cell type and stage of development, actually determines the net effects of a particular combination of interactive cytokines. Clearly, the mechanisms of these interactions will need to be elucidated to better understand their biological function and to permit cytokines to be used clinically to the advantage of the host.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550874

Source DB:  PubMed          Journal:  Immunol Ser        ISSN: 0092-6019


  20 in total

Review 1.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

Review 2.  Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors:  G J del Zoppo; S Wagner; M Tagaya
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

3.  Exogenous tumor necrosis factor alpha and interleukin-1 alpha increase resistance to Salmonella typhimurium: efficacy is influenced by the Ity and Lps loci.

Authors:  P J Morrissey; K Charrier; S N Vogel
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

4.  Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: comparison with a human whole blood culture test system and with the rabbit pyrogen test.

Authors:  Yukari Nakagawa; Hideko Maeda; Toshimi Murai
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

5.  Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.

Authors:  S Yende; G W Waterer; E A Tolley; A B Newman; D C Bauer; D R Taaffe; R Jensen; R Crapo; S Rubin; M Nevitt; E M Simonsick; S Satterfield; T Harris; S B Kritchevsky
Journal:  Thorax       Date:  2005-11-11       Impact factor: 9.139

6.  Sexual dimorphism on cytokines expression in the temporomandibular joint: the role of gonadal steroid hormones.

Authors:  Karla E Torres-Chávez; Luana Fischer; Juliana Maia Teixeira; Nadia Cristina Fávaro-Moreira; Gustavo Alberto Obando-Pereda; Carlos Amílcar Parada; Claudia Herrera Tambeli
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

7.  TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies.

Authors:  Matthew D McGeough; Alexander Wree; Maria E Inzaugarat; Ariela Haimovich; Casey D Johnson; Carla A Peña; Raphaela Goldbach-Mansky; Lori Broderick; Ariel E Feldstein; Hal M Hoffman
Journal:  J Clin Invest       Date:  2017-11-13       Impact factor: 14.808

8.  Enhancing the immunotherapeutic potential of mycobacteria by transfection with tumour necrosis factor-alpha.

Authors:  J L Haley; D G Young; A Alexandroff; K James; A M Jackson
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

Review 9.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

10.  Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats.

Authors:  T Cartmell; C Ball; A F Bristow; D Mitchell; S Poole
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.